Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 4, 2004, Pages 818-820

  Meka, Venkata G ^a   Gold, Howard S ^a   Cooke, Amy ^b   Venkataraman, Lata ^a   Eliopoulos, George M ^a   Moellering Jr , Robert C ^a   Jenkins, Stephen G ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

23S rRNA gene; G2576T mutation; Gene conversion

Indexed keywords

ERYTHROMYCIN; GUANINE; LINEZOLID; RIBOSOME DNA; RIBOSOME RNA; RNA 23S; THYMINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; GENE CONVERSION; GENE MUTATION; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC STABILITY; HOMOLOGOUS RECOMBINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; OXAZOLIDINONES; RNA, RIBOSOMAL, 23S; STAPHYLOCOCCUS AUREUS;

EID: 6344253214     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh423     Document Type: Article

References (15)

1. Shinabarger, D. L. (1999). Mechanism of action of the oxazolidinone antibacterial agents. Expert Opinion on Investigational Drugs 8, 1195-202.
2. Matassova, N. B., Rodnina, M. V., Endermann, R. et al.] (1999). Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors. RNA 5, 939-46.
3. Xiong, L., Kloss, P., Douthwaite, S. et al.] (2000). Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. Journal of Bacteriology 182, 5325-31.
4. Swaney, S. M., Shinabarger, D. L., Schaadt, R. D., et al.] (1998). Oxazolidinone resistance is associated with a mutation in the peptidyl transferase region of 23S rRNA. In Abstracts of the Thirty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract C-104, p. 98. American Society for Microbiology, Washington, DC, USA.
5. Klappenbach, J. A., Saxman, P. R., Cole, J. R. et al.] (2001). rrndb: the Ribosomal RNA Operon Copy Number Database. Nucleic Acids Research 29, 181-4.
6. Tsiodras, S., Gold, H. S., Sakoulas, G. et al.] (2001). Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358, 207-8.
7. Wilson, P., Andrews, J. A., Charlesworth, R. et al.] (2003). Linezolid resistance in clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 51, 186-8.
8. Machado, A. R. L., Andrade, S. S., Barth, A. L., et al.] (2003). The emergence of linezolid-resistance among Staphylococcus aureus from cystic fibrosis patients. In Abstracts of the Forty-third Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2003. Abstract C2-1825, p. 144. American Society for Microbiology, Washington, DC, USA.
9. Paterson, D. L., Potoski, B. A., Kolano, J., et al.] (2003). Fatal infection due to Staphylococcus aureus with decreased linezolid susceptibility. In Abstracts of the Forty-third Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2003 Abstract K-1405, p. 385. American Society for Microbiology, Washington, DC, USA.
10. Meka, V. G., Pillai, S. K., Sakoulas, G. et al.] (2004). Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. Journal of Infectious Diseases 190, 311-7.
11. Pillai, S. K., Sakoulas, G., Wennersten, C. et al.] (2002). Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. Journal of Infectious Diseases 186, 1603-7.
12. Marshall, S. H., Donskey, C. J., Hutton-Thomas, R. et al.] (2002). Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 46, 3334-6.
13. Zurenko, G. E., Todd, W. M., Hafkin, B., et al.] (1999). Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid. In Abstracts of the Thirty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 848, p. 118. American Society for Microbiology, Washington, DC, USA.
14. Prammananan, T., Sander, P., Springer, B. et al.] (1999). RecA-mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrobial Agents and Chemotherapy 43, 447-53.
15. Lobritz, M., Hutton-Thomas, R., Marshall, S. et al.] (2003). Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 47, 3318-20.